Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

5.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Angioedema Presenting as Infant-Onset Primary Lymphedema.

Journal of vascular anomalies·2026
Same author

Primary Upper Extremity Lymphedema Caused by a <i>CELSR1</i> Variant.

Journal of vascular anomalies·2026
Same author

Correction: MRC1 and LYVE1 expressing macrophages in vascular beds of GNAQ p.R183Q driven capillary malformations in Sturge Weber syndrome.

Acta neuropathologica communications·2026
Same author

Prenatal Lymphedema: A Genotype-Phenotype Analysis.

Journal of vascular anomalies·2026
Same author

Rheumatological Diseases and Lower Extremity Edema: A Lymphoscintigram Study.

Journal of vascular anomalies·2026
Same author

MAPK signaling and angiopoietin-2 contribute to endothelial permeability in capillary malformations.

Proceedings of the National Academy of Sciences of the United States of America·2025

Related Experiment Video

Updated: Jul 24, 2025

A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

5.4K

Arteriovenous malformation Map2k1 mutation affects vasculogenesis.

Christopher L Sudduth1, Patrick J Smits1, Matthew P Vivero1

  • 1Department of Plastic and Oral Surgery, Boston Children's Hospital, Harvard Medical School, 300 Longwood Ave., Boston, MA, 02115, USA.

Scientific Reports
|July 8, 2023
PubMed
Summary
This summary is machine-generated.

Somatic mutations in MAP2K1 cause arteriovenous malformations (AVMs). This study reveals how mutant MAP2K1 in endothelial cells alters gene expression, impacting pathways crucial for blood vessel development and AVM formation.

More Related Videos

Adult Mouse Venous Hypertension Model: Common Carotid Artery to External Jugular Vein Anastomosis.
08:27

Adult Mouse Venous Hypertension Model: Common Carotid Artery to External Jugular Vein Anastomosis.

Published on: January 27, 2015

14.2K
Cerebrovascular Casting of the Adult Mouse for 3D Imaging and Morphological Analysis
06:42

Cerebrovascular Casting of the Adult Mouse for 3D Imaging and Morphological Analysis

Published on: November 30, 2011

21.8K

Related Experiment Videos

Last Updated: Jul 24, 2025

A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

5.4K
Adult Mouse Venous Hypertension Model: Common Carotid Artery to External Jugular Vein Anastomosis.
08:27

Adult Mouse Venous Hypertension Model: Common Carotid Artery to External Jugular Vein Anastomosis.

Published on: January 27, 2015

14.2K
Cerebrovascular Casting of the Adult Mouse for 3D Imaging and Morphological Analysis
06:42

Cerebrovascular Casting of the Adult Mouse for 3D Imaging and Morphological Analysis

Published on: November 30, 2011

21.8K

Area of Science:

  • Vascular Biology
  • Genetics
  • Developmental Biology

Background:

  • Somatic activating mutations in MAP2K1 are implicated in endothelial cell (EC) dysfunction leading to extracranial arteriovenous malformations (AVMs).
  • Previous work established a mouse model (R26GT-Map2k1-GFP/+) with inducible expression of constitutively active MAP2K1 (p.K57N) in ECs, demonstrating its sufficiency in causing vascular malformations.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which mutant MAP2K1 drives AVM development.
  • To identify key genes and pathways affected by MAP2K1 overexpression in ECs during early postnatal development.

Main Methods:

  • Inducible expression of mutant MAP2K1 (p.K57N) in ECs of postnatal day-1 mouse pups.
  • RNA sequencing (RNA-seq) analysis of brain ECs from mutant and wild-type littermates at postnatal day 9.
  • Immunostaining to validate differential gene expression, specifically for COL15A1.

Main Results:

  • Overexpression of mutant MAP2K1 in ECs altered the transcript abundance of over 1600 genes.
  • Significant fold-changes were observed in genes such as Col15a1 (39-fold) and Itgb3 (24-fold).
  • Gene ontology analysis revealed enrichment in pathways critical for vasculogenesis, including cell migration, adhesion, extracellular matrix organization, tube formation, and angiogenesis.

Conclusions:

  • Mutant MAP2K1 expression profoundly impacts the EC transcriptome, driving changes in genes essential for vascular development.
  • The identified differentially expressed genes and pathways offer potential therapeutic targets for AVMs.
  • Further investigation into these specific genes and pathways will enhance understanding of AVM pathogenesis.